NWBO · Northwest Biotherapeutics Inc · Executive Compensation
$0.17
0.00 (-0.99%)
At close · Aug 21
Return incl. dividend (before tax)
Going-concern doubt
— flagged Aug 14, 2026
Substantial doubt about the company's ability to continue as a going concern.
“Because of recurring operating losses and operating cash flow deficits, there is substantial doubt about the Company’s ability to continue as a going concern for at least one year from the date of this filing. The consolidated financial statements have been prepared assuming that the Company will continue as a going concern, however, they do not include any adjustments to reflect the possible future effects on the recoverability and classification of assets, or the amounts and classification of liabilities that may result from the outcome of this uncertainty.”View the 10-Q filed Aug 14, 2026
Market Cap
$289.96M
Shares
1.71B
Volume · Aug 21
3.19M
Avg daily vol (3M)
2.98M
Named-executive compensation from the company's DEF 14A proxy statements — salary, bonus, stock and option awards, non-equity incentive, and the company-reported total per executive per fiscal year, exactly as disclosed in the Summary Compensation Table.
Fiscal 2024
| Executive | Role | Total |
|---|---|---|
| Linda F. Powers | Chairperson, President & Chief Executive Officer, Chief Financial and Accounting Officer Leslie Goldman Former Senior Vice President and General Counsel | $1,225,000 |
Fiscal 2023
| Executive | Role | Total |
|---|---|---|
| Linda F. Powers | Chairperson, President & Chief Executive Officer, Chief Financial and Accounting Officer Leslie Goldman Former Senior Vice President and General Counsel | $1,225,000 |
| Marnix L. Bosch | Chief Technical Officer | $633,600 |
| Alton L. Boynton | Ph.D. Chief Scientific Officer and Secretary | $375,000 |
Fiscal 2022
| Executive | Role | Total |
|---|---|---|
| Marnix L. Bosch | Ph.D. Chief Technical Officer | $597,500 |
| Alton L. Boynton | Ph.D. Chief Scientific Officer and Secretary | $450,000 |
Fiscal 2021
| Executive | Role | Total |
|---|---|---|
| Linda F. Powers | Chairperson, President and Chief Executive Officer, Chief Financial and Accounting Officer | $1,000,000 |
| Leslie J. Goldman | Senior Vice President,General Counsel and Business Development | $725,000 |
| Marnix L. Bosch | Ph.D. Chief Technical Officer | $567,500 |
| Alton L. Boynton | Ph.D. Chief Scientific Officer and Secretary | $425,000 |
Fiscal 2020
| Executive | Role | Total |
|---|---|---|
| Linda F. Powers | Chairperson, President and Chief Executive Officer, Chief Financial and Accounting Officer | $18,017,000 |
| Leslie J. Goldman | Senior Vice President, General Counsel and Business Development | $11,073,000 |
| Marnix L. Bosch | Chief Technical Officer | $7,974,000 |
Fiscal 2019
| Executive | Role | Total |
|---|---|---|
| Linda F. Powers | Chairperson, President and Chief Executive Officer, Chief Financial and Accounting Officer | $802,000 |
| Leslie J. Goldman | Senior Vice President, General Counsel and Business Development | $575,000 |
| Jean M. Davis | Chief Financial Officer, Chief Accounting Officer and Interim Chief Information Officer | $516,000 |
| Marnix L. Bosch | Chief Technical Officer | $497,000 |
| Alton L. Boynton | Chief Scientific Officer and Secretary | $345,000 |
Fiscal 2018
| Executive | Role | Total |
|---|---|---|
| Linda F. Powers | Chairperson, President & Chief Executive Officer | $7,200,000 |
| Leslie J. Goldman | Senior Vice President, General Counsel | $4,561,000 |
| Alton L. Boynton | Chief Scientific Officer and Secretary | $1,853,000 |
| Marnix L. Bosch | Chief Technical Officer | $635,000 |
Executive changes
| Person | Role | Change | Filed |
|---|---|---|---|
| Pat Sarma | Class II director | Appointed | 2024-03-22 |
| Jerry Jasinowski | Board of Directors | Retired | 2024-03-14 |